补充化质子复合体用于瘤微环境重编程:一种针对华堡效应和线粒体功能障碍的生物能量策略
Alfred Lee Edgar1, Luis Felipe Dias Lopes2, Eduarda Grando Lopes3
1Research and Development Department, ElastroCrete, LLC, Veyo, UT, United States.
Frontiers in oncology
|September 22, 2025
概括
伊根/津德尔复合物富含水 (EZC-Rich Water) 提供了一种通过恢复线粒体功能来重新编程瘤微环境 (TME) 的新方法. 该策略针对代谢失调和pH不平衡,显示了癌症治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 生物能源学 生物能源学
- 物理化学 物理化学
背景情况:
- 瘤微环境 (TME) 呈现反向的pH梯度,促进瘤的进展和治疗阻力.
- 线粒体功能障碍和代谢重编程是TME变化的关键驱动因素.
- 目前,TME生物能源重编程的有效策略有限.
研究的目的:
- 引入和评估Eigen/Zundel复合物富含水 (EZC富含水) 作为一种新的化质子补充策略.
- 针对华堡诱导的质子失调,并在TME中恢复线粒体功能.
- 为了稳定电化学膜动力学和纠正TME中的pH逆转.
主要方法:
- 采用了翻译性研究设计,结合了工作分解结构,开放式创新和设计思维.
- 确定了基本观点 (生理目标) 和关键成功因素 (机制要求).
- 应用多标准决策分析,结合瘤学,生物能学和物理化学的发现.
主要成果:
- EZC-Rich Water提供了转移稳定的化质子团 (H9O4+和H5O2+),通过Grotthuss机制支持高效的质子转移.
- 补充剂促进了分隔的酸调制,没有系统性酸症.
- 证明了优化氧化酸化和恢复TME中的生物能量完整性的潜力.
结论:
- EZC-Rich Water代表了一种创新的生物能源干预措施,用于重新编程TME.
- 该策略针对的是代谢功能障碍,如沃堡效应和线粒体脱.
- 它具有临床适应性和低风险,为营养瘤学提供了一个新的范式,需要进一步研究.
更多相关视频
10:23Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
Published on: December 1, 2023
961
08:15Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
Published on: February 3, 2022
3.6K
相关概念视频
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
